Car T against a solid tumour! Something thought not possible only a few years ago. And now a little ozzy minnow, CHM, has proved it twice! With two separate drugs!
The market cap is unbelievable!
Another drug in the pipeline adds NK cells to the Cd17 drug I think. So there is much more to come!
Of course the NK cells have given 3 CRs so far in trial.
Hopefully the financial risk can be put to rest next week.
Hats off to Bec. She hit the ground running and is performing to such a high standard.
CHM Price at posting:
0.7¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)